Clinical Trial Update: Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Reactivity in Patients With ST-elevation Myocardial Infarction (STEMI) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing prasugrel with clopidogrel for inhibition of platelet reactivity in ST-elevation myocardial infarction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-elevation Myocardial Infarction

Drugs mentioned

• EFFIENT (prasugrel hydrochloride)
• Plavix (clopidogrel)

Snippet

Sponsor: University of Patras | Conditions: Myocardial Infarction | Phase 3 | Status: COMPLETED